Brief: Biontech SE Reports 12.5% Stake In Autolus Therapeutics PLC As Of February 13, 2024
21/02/2024 23:22
Feb 21 (Reuters) - Autolus Therapeutics PLC AUTL.O :
* BIONTECH SE REPORTS 12.5% STAKE IN AUTOLUS THERAPEUTICS
PLC AS
OF FEBRUARY 13, 2024- SEC FILING
Source text for Eikon: ID:n0001193125-24-041581
Further company coverage: AUTL.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Autolus Therapeutics
See all newsBrief: Autolus Therapeutics PLC Unit Enters Master Service Agreement With AGC Biologics
Brief: Autolus Therapeutics Appoints Ryan Richardson To Board Of Directors
Brief: Nice Recommends Aucatzyl As A Treatment Option For Adult Patients With Lymphoblastic Leukemia
Brief: Autolus Therapeutics’ Car T Therapy Aucatzyl® (Obecabtagene Autoleucel) Granted European Marketing Authorization For Adult Patients
Brief: Autolus Therapeutics Announces Inducement Grants